Résultats de la recherche
10
Tout
Salipro Biotech et Boehringer Ingelheim concluent un accord de recherche et de licence en vue d’accélérer plusieurs programmes du pipeline de Boehringer Ingelheim
13 mars 2025 09h00 HE
|
Salipro Biotech AB
STOCKHOLM, 13 mars 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, société suédoise de biotechnologie spécialisée dans la stabilisation de cibles pharmacologiques difficiles à étudier, a annoncé ce...
Salipro Biotech und Boehringer Ingelheim schließen Forschungs- und Lizenzvertrag zur Beschleunigung mehrerer Pipeline-Programme von Boehringer Ingelheim
13 mars 2025 09h00 HE
|
Salipro Biotech AB
STOCKHOLM, March 13, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, ein schwedisches Biotechnologieunternehmen, das sich auf die Stabilisierung anspruchsvoller Wirkstoffziele spezialisiert hat, gab...
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
13 mars 2025 09h00 HE
|
Salipro Biotech AB
Salipro Biotech and Boehringer Ingelheim enter research and license agreement to accelerate multiple Boehringer Ingelheim pipeline programs.
Active Pharmaceutical Ingredients Market To Reach USD 346.4 Billion By 2032 at CAGR 8.7%| DataHorizzon Research
15 janv. 2024 07h30 HE
|
DataHorizzon Research
Colorado, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The Active Pharmaceutical Ingredients (API) Market size was valued at USD 151.2 Billion in 2022 and is expected to reach USD 346.4 Billion by 2032 at a...
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
30 oct. 2023 03h20 HE
|
Burning Rock Biotech Limited
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
Amgen’s Amjevita Remains the Frontrunner in the US Adalimumab Biosimilars Market, Despite Increased Competition, According to Spherix Global Insights.
14 sept. 2023 11h37 HE
|
Spherix Global Insights
Exton, Pennsylvania, Sept. 14, 2023 (GLOBE NEWSWIRE) -- This summer ushered in the highly anticipated introduction of a multitude of additional adalimumab biosimilars to the dynamic US immunology...
Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market
28 juin 2023 08h30 HE
|
Minerva Neurosciences, Inc
BURLINGTON, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...
RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence
21 avr. 2023 03h00 HE
|
RetinAI Medical AG
BERN, Switzerland and BOSTON, April 21, 2023 (GLOBE NEWSWIRE) -- RetinAI Medical AG (“RetinAI”), a leader in clinical and imaging data management software and advanced analytics using artificial...
ALBERTA BOEHRINGER INGELHEIM COLLABORATION FUND ANNOUNCES NEW RESEARCH FOR PATIENTS LIVING WITH RESPIRATORY DISEASE
24 sept. 2019 18h11 HE
|
University Hospital Foundation
Edmonton, Alberta, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Boehringer Ingelheim (Canada) Ltd., the University Hospital Foundation, and the Government of Alberta are proud to announce the winners of the...
Animal Parasiticides Market Advancing With Rising Animal Welfare Concerns - IndustryARC Research
20 mars 2017 14h45 HE
|
IndustryARC
Hyderabad, India, March 20, 2017 (GLOBE NEWSWIRE) -- The report “Animal Parasiticides Market Analysis: By Product Type (Ectoparasiticides, Endoparasiticides, Endectocides), By Type of Animal...